The company behind a potential Ebola drug is red-hot again.
Canadian biotech firm Tekmira Pharmaceuticals (TKMR)announced that the Federal Drug Administration knocked down a key barrier to its medicine, TKM Ebola, reaching some patients. The FDA moved the drug from a "full hold" to a "partial hold," which means Tekmira can use the drug in limited experiments.
FDA allows limited use of Ebola drug. Tekmira stock spikes 45% - Aug. 8, 2014
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.